Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,394.30
3.50 (0.25%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹75.27K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
84.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹641.05+117.5%
52W High₹1,457-4.3%
Current Price
₹1,394.30
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,115.44
Upper Circuit₹1,673.16
Reference Price
₹1,394.30
Investment Checklist
Double Bottom on 1W (BREAKOUT CONFIRMED) — target ₹1289.15
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1028.15
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
Composite score 44.6 (BUY) with 81.7% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
82%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1362.97
EMA50
1264.38
EMA200
1058.19
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹1142.92
₹1103.55
₹1080.00
₹1068.00
₹1031.72
Volume Analysis
TrendSTABLE
Change-1.40%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹1380.36
3% Risk₹1352.47
5% Risk₹1324.58
7% Risk (Custom)
₹1296.70Technical Levels
1x ATR (Volatility)₹1359.17
2x ATR (Swing)₹1324.04
3x ATR (Trend)₹1288.91
Immediate Support₹1142.92
Moving Averages
EMA 20 (Medium-term)₹1362.97
EMA 50 (Trend)₹1264.38
EMA 200 (Long-term)₹1058.19
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,415.1 Cr | ₹1,674.2 Cr | ₹1,569.6 Cr | ₹1,778.3 Cr |
| Net Profit | ₹92.3 Cr | ₹233.7 Cr | ₹163 Cr | ₹251.7 Cr |
| EPS | ₹1.71 | — | ₹3.02 | ₹4.67 |
| Operating Profit | ₹294.6 Cr | ₹469.8 Cr | ₹392.6 Cr | ₹486 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| BIOCON | Biocon Limited | ₹419.00 | +0.73% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 08 May 2026 | Interim Dividend - Rs 1.20 Per Share | INTERIM_DIVIDEND |
| 31 Oct 2025 | Interim Dividend - Re 0.80 Per Sh | INTERIM_DIVIDEND |
| 09 May 2025 | Interim Dividend - Rs 0.80 Per Share | INTERIM_DIVIDEND |
| 06 Nov 2024 | Interim Dividend - Rs 0.40 Per Share | INTERIM_DIVIDEND |
| 04 Jul 2024 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for LAURUSLABS
View All
positive
Business Standard - Markets 8d ago
Sai Life, Laurus Labs hit new highs; stocks rally up to 40% in 6 months
Sai's management reiterated long-term guidance of 15-20 per cent revenue CAGR with 28-30 per cent steady state EBITDA margin over the next two to three years.
ABSLNN50ETLAURUSLABSLTGILTBEESNAM-INDIASAILIFEFinancial ServicesHealthcare
positive
LiveMint - Markets 8d ago
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends 3 stocks to buy today amid RBI policy - 5 June 2026
Shares to buy or sell: Chandan Taparia has recommended three stocks to buy today, 5 June 2026 - BSE, Laurus Labs and Exide Industries shares.
BSECHANDANEXIDEINDLAURUSLABSMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEAutomobile and Auto ComponentsFinancial Services
positive
ET Markets - Stocks 11d ago
Market Trading Guide: NMDC among two stock recommendations for Tuesday
Indian benchmark indices extended losses for a fourth straight session as FII selling and geopolitical concerns hurt sentiment. Amid the weakness, analysts recommend NMDC and Laurus Labs, citing bullish chart patterns, strong momentum, breakout formations and favorable technical indicators for further upside.
AONETMMQ50LAURUSLABSMOMENTUMNMDCFinancial ServicesHealthcare